Vaxart Inc’s recently made public that its Former Executive Officer Lee Phillip E (VXRT) acquired Company’s shares for reported $37427.0 on May 27 ’25. In the deal valued at $0.46 per share,81,364 shares were bought.
Then, Lo Steven bought 100,000 shares, generating $49,000 in total proceeds. Upon buying the shares at $0.49, the President, Chief Exec Officer now owns 100,000 shares.
Before that, Watson W. Mark bought 20,000 shares. Vaxart Inc shares valued at $13,578 were divested by the Director at a price of $0.68 per share. As a result of the transaction, Watson W. Mark now holds 78,125 shares, worth roughly $33593.75.
Oppenheimer initiated its Vaxart Inc [VXRT] rating to an Outperform in a research note published on August 15, 2024; the price target was $4. Cantor Fitzgerald began covering VXRT with “an Overweight” recommendation on November 02, 2021. B. Riley Securities revised its rating on June 29, 2021. It rated VXRT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of VXRT
On Friday, Vaxart Inc [NASDAQ:VXRT] saw its stock fall -7.32% to $0.43. Over the last five days, the stock has lost -7.85%. Vaxart Inc shares have fallen nearly -34.59% since the year began. Nevertheless, the stocks have fallen -47.77% over the past one year. While a 52-week high of $1.07 was reached on 01/07/25, a 52-week low of $0.28 was recorded on 04/09/25. SMA at 50 days reached $0.4123, while 200 days put it at $0.6446.
Levels Of Support And Resistance For VXRT Stock
The 24-hour chart illustrates a support level at 0.4101, which if violated will result in even more drops to 0.3870. On the upside, there is a resistance level at 0.4631. A further resistance level may holdings at 0.4930. The Relative Strength Index (RSI) on the 14-day chart is 48.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0042, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.88%. Stochastics %K at 47.14% indicates the stock is a holding.
The most recent change occurred on June 24, 2021 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
